19/03/2009 by Merav.

Come along to hear the .. .

‘Confessions of a Drug Rep’

We will be hearing from Shahram Ahari who is a former pharmaceutical sales representative from Eli Lilly’s Neuroscience Division where he successfully sold the blockbuster drugs olanzapine (Zyprexa) and fluoxetine (Prozac) until he left the industry to pursue public health and social justice issues.

In the past 3 years, Mr. Ahari has given over 90 medical lectures nationally and internationally on topics such as global access to essential medicines, drug marketing’s impact on public health, and the drug rep - physician relationship. He has been a speaker for the AMA (American Medical Association), AMSA, IFMSA (International Federation of Medical Students) among other organizations. Mr. Ahari advises private and government institutions on policy issues related to the drug industry. He has testified before the US Senate, the House of Representatives and has served as an expert in matters of drug marketing, public health and policy. He has appeared on numerous media programs including CNBC Business Nation, ABC Worldnews, CBS Evening News, The NY Times, The LA Times, The Washington Post, Rolling Stone Magazine, National Public Radio and American Public Radio for his work on public health and drug marketing.

Mr. Ahari earned a B.A. in Biochemistry, Molecular Biology and Asian Studies from Rutgers College and has a Masters in Public Health with specialties in Infectious Disease and International Health from UC Berkeley.

Monday 23rd March @ 7pm

Seminar Room 119, SAF Building
Imperial College London, South Ken, SW7 2AZ (map attached)

Posted in PharmAware News | Print | No Comments »

22/09/2008 by Merav.

Bristol will be holding the pharmaware AGM in February 2009. The team would like to get some input from you, current members as to what content you would like to include in this AGM, especially if there is anything that you would like clarified or would help a new branch to grow. They would also like to know if anyone has any suggestions for the debate to be held at this AGM. Contact them at Bristol@pharmaware.co.u

Posted in PharmAware News | Print | No Comments »